Navigation Links
Inflammatory Substance May Boost Eye Trouble
Date:10/8/2007

C-reactive protein raises odds of age-related macular degeneration, experts say

MONDAY, Oct. 8 (HealthDay News) -- People with high blood levels of C-reactive protein, a substance associated with inflammation, may be at higher risk of developing age-related macular degeneration (AMD), a major cause of vision loss in older adults.

Dutch researchers collected blood samples and took photographs of the eyes of more than 4,900 people at risk for AMD. They then followed the group for an average of 7.7 years.

During that time, 658 of the participants were diagnosed with AMD -- 561 with initial stage AMD and 97 with advanced AMD.

As an individual's C-reactive protein level increased above the midpoint of the study group, the person became more and more likely to develop AMD, the researchers found.

The study is published in the October issue of the journal Archives of Ophthalmology.

The findings suggest that lowering C-reactive protein levels may help decrease AMD risk, the study authors said.

"A substance that can selectively inhibit C-reactive protein synthesis has not yet been developed, to our knowledge," wrote a team from Erasmus Medical Center, Rotterdam. "Smoking and high body mass index increase C-reactive protein levels. Moderate alcohol intake, diets with a low glycemic index and statin [drugs] and multivitamin use reduce C-reactive protein levels."

It's known that smoking and obesity increase the risk of AMD, which occurs when the macula -- the area at the back of the retina involved in sharp vision -- deteriorates over time.

More information

The U.S. National Eye Institute has more about AMD.



-- Robert Preidt



SOURCE: JAMA/Archives journals, news release, Oct. 8, 2007


'/>"/>
Copyright©2007 ScoutNews,LLC.
All rights reserved

Related medicine news :

1. Inflammatory bowel disease linked to genetic abnormality
2. Safeguarding anti-inflammatory users from ulcers
3. Gel pares inflammatory activity throughout body
4. The Usage Of Anti-Inflammatory Drugs Questioned
5. Hope For Patients With Inflammatory Bowel Disease
6. FDA to bring about changes in Marketed Non-Steroidal Anti-Inflammatory Drugs
7. Anti-inflammatory drugs reduce the risk of oral cancer for smokers
8. Elevated Insulin Levels To Influence Levels Of Inflammatory Markers
9. Cannabinoids drug for inflammatory bowel
10. Cannabinoids - Antidepressant And Inflammatory Bowel Disease Treatment
11. Ambiguous Efficacy Of Opioid Drugs In Chronic Inflammatory Joint Pain Relief
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... The Pulmonary Hypertension ... that it will receive two significant new grants to support its work to ... its 25th anniversary by recognizing patients, medical professionals and scientists for their work ...
(Date:6/24/2016)... ... ... Comfort Keepers® of San Diego, CA is excited to announce they are ... drive cancer patients to and from their cancer treatments. Comfort Keepers provides quality ... and ongoing independence. Getting to and from medical treatments is one of the ...
(Date:6/24/2016)... ... June 24, 2016 , ... EB ... Decision Making in Emergency Medicine conference in Ponte Vedra Beach, FL. The awards ... in Emergency Medicine Practice and Pediatric Emergency Medicine Practice. , “With ...
(Date:6/24/2016)... ... June 24, 2016 , ... ... the Frederick area economy by obtaining investment capital for emerging technology companies. ... years that have already resulted in more than a million dollars of capital ...
(Date:6/24/2016)... , ... June 24, 2016 , ... ... human induced pluripotent stem (iPS) cells and other difficult to transfect cells, announces ... Medium. The PluriQ™ G9™ Gene Editing System is a complete system ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... , June 24, 2016 Dehaier Medical ... the "Company"), which develops, markets and sells medical devices ... , signed a strategic cooperation agreement with Hongyuan ... "Hongyuan Supply Chain") on June 20, 2016, to develop ... the strategic cooperation agreement, Dehaier will leverage Hongyuan Supply ...
(Date:6/24/2016)... Belgium , June 24, 2016 ... the appointment of Dr. Edward Futcher ... Non-Executive Director, effective June 23, 2016.Dr. Futcher was ... Nominations and Governance Committees.  As a non-executive member ... independent expertise and strategic counsel to VolitionRx in ...
(Date:6/23/2016)... , June 23, 2016 Research ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, Petrochemical, ... (Oral, Topical, Coating, Parenteral) - Global Forecast to 2021" ... The global pharmaceutical excipients market is ... a CAGR of 6.1% in the forecast period 2016 ...
Breaking Medicine Technology: